SC 13G/A 1 d500737dsc13ga.htm SC 13G/A SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 7)*

 

 

 

Community First, Inc.

(Name of issuer)

 

 

 

Common Stock, no par value

(Title of class of securities)

 

203663 10 9

(CUSIP number)

 

May 18, 1999

(Date of event which requires filing of this statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

þ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

SCHEDULE 13G

 

CUSIP No. 203663 10 9   Page 2 of 5 Pages

 

  (1)   

Names of reporting persons

 

Eslick E. Daniel, M.D.

  (2)  

Check the appropriate box if a member of a group (see instructions)

(a)  ¨        (b)  ¨

 

  (3)  

SEC use only

 

  (4)  

Citizenship or place of organization

 

United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

    (5)    

Sole voting power

 

57,098

   (6)   

Shared voting power

 

157,638

   (7)   

Sole dispositive power

 

57,098

   (8)   

Shared dispositive power

 

157,638

  (9)

  

Aggregate amount beneficially owned by each reporting person

 

214,736

(10)

  

Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

 

¨

(11)

  

Percent of class represented by amount in Row (9)

 

6.56%

(12)

  

Type of reporting person (see instructions)

 

IN

 

Page 3 of 5 Pages

 

                        

Item 1(a).   Name of Issuer:

      Community First, Inc.

Item 1(b).  Address of Issuer’s Principal Executive Offices:

      501 S. James M. Campbell

Columbia, TN 38401

Item 2(a).   Name of Person Filing:

      See Item 1 of page 2

Item 2(b).  Address of Principal Business Office or, if none, Residence:

      1223  1/2 Trotwood Avenue

Columbia, TN 38401

Item 2(c).   Organization/Citizenship:

      See Item 4 of page 2

Item 2(d).  Title of Class Of Securities:

      Common Stock, no par value

Item 2(e).   CUSIP Number:

      203663 10 9

Item 3.        Inapplicable.

     

Item 4.        Ownership.

     
    

 

                                                                                                                                                     

Person

      Total Shares
of
Common
Stock
Beneficially
Owned		        Percent
of
Class(1)		     Sole
Voting
Power		        Shared
Voting
Power		        Sole
Power
to
Dispose		        Shared
Power
to
Dispose		  

Eslick E. Daniel, M.D.

        214,736           6.56 %      57,098           157,638           57,098           157,638   

 

 

(1) Based on 3,274,305 shares of Common Stock outstanding as of December 31, 2012.

Page 4 of 5 Pages

 

Item 5. Ownership of Five Percent or Less of a Class.

Inapplicable

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Inapplicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Inapplicable

 

Item 8. Identification and Classification of Members of the Group.

Inapplicable

 

Item 9. Notice of Dissolution of Group.

Inapplicable

 

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

March 12, 2013

Date

/s/ Eslick E. Daniel, M.D.

(Signature)

Eslick E. Daniel, M.D.

(Name/Title)